Scientists at the CSIC have developed a neuroprotective peptide which can be useful in the treatment and prevention of stroke or cerebral ischemia and other situations that cause brain damage. In vitro experiments have shown its efficacy when used on cultured neurons. Partners interested in licensing the patent are sought.
Two-layer dressings that facilitate the healing of wounds have been developed by CSIC scientists. The dressings are specially indicated for patients with low blood supply, with diabetes or elderly people. The product has been patented. Industrial partners are sought for license agreements or for keeping on with the research.
Scientists at the Instituto de Recursos Naturales y Agrobiologia de Salamanca (IRNASA) have obtained a method to detect the soft thick O.moubata. Also they are studying the tick saliva as a valuable source for drugs and vaccines.
Scientists at CSIC and at University of La Laguna have patented new compounds derived from tamoxifen, one of the most commonly used cancer-fighting drugs. The new molecules could be used as an alternative treatment to tamoxifen, as they don't have its adverse effects, and as diagnostic biomarkers due to their fluorescence quality. They could be used also as a laser pigment.
Scientists at CSIC and at the Imperial College London have synthesized a new peptide that promotes and inhibits inflammatory pattern in intestinal dendritic cells.
The antioxidant enzyme SOD-3 (superoxide dismutase-3), which is produced in the human cell membrane, can help the immune system to eliminate tumour cells, as scientists found out. The discovery suggests new strategies to fight cancer.
Plants injected with virus. Left, a non resistant plant. Right, a resistant plant. Picture: CSIC. CSIC scientists at the the Centro de Edafología y Biología Aplicada del Segura (CEBAS) have developed a method to generate varieties of cucurbits (which includes species such as melon, cucumber, watermelon or pumpkins) resistant to several viral diseases. The method is based on silencing a gene of the plant wich expresses a protein used by the virus for its own replication and spreading of the infection. No foreign elements are introduced, which reduces the chance of unexpected repercussions. Contact: Vicepresidencia Adjunta de Transferencia del Conocimiento /CEBAS - CSIC Yolanda Hernando Tel. +(34) 968 39 63 56 This email address is being protected from spambots. You need JavaScript enabled to view it.
Scientists from the CSIC have designed a group of anti-inflammatory compounds, derivates of resveratrol, which have been patented. An experiment to test the new molecules against ulcerative colitis has shown that they are effective in very small quantities.
Researchers from the CSIC and two spanish universities have developed new propargylamine derivatives for the treatment of neurodegenerative diseases, particularly Alzheimer's.
